Cargando…
Biosimilar, biobetter and next generation therapeutic antibodies
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Landes Bioscience
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092613/ https://www.ncbi.nlm.nih.gov/pubmed/21285536 http://dx.doi.org/10.4161/mabs.3.2.14785 |
_version_ | 1782203389920149504 |
---|---|
collection | PubMed |
description | |
format | Text |
id | pubmed-3092613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-30926132012-03-01 Biosimilar, biobetter and next generation therapeutic antibodies MAbs Editorial Landes Bioscience 2011 2011-03-01 /pmc/articles/PMC3092613/ /pubmed/21285536 http://dx.doi.org/10.4161/mabs.3.2.14785 Text en Copyright © 2011 Landes Bioscience Open Access |
spellingShingle | Editorial Biosimilar, biobetter and next generation therapeutic antibodies |
title | Biosimilar, biobetter and next generation therapeutic antibodies |
title_full | Biosimilar, biobetter and next generation therapeutic antibodies |
title_fullStr | Biosimilar, biobetter and next generation therapeutic antibodies |
title_full_unstemmed | Biosimilar, biobetter and next generation therapeutic antibodies |
title_short | Biosimilar, biobetter and next generation therapeutic antibodies |
title_sort | biosimilar, biobetter and next generation therapeutic antibodies |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092613/ https://www.ncbi.nlm.nih.gov/pubmed/21285536 http://dx.doi.org/10.4161/mabs.3.2.14785 |